Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors

Miscellaneous

Open-label study using ASP-1929 photoimmunotherapy in combination with anti-PD1 therapy in patients with recurrent or metastatic head and neck and squamous cell cancer or advanced or metastatic cutaneous squamous cell carcinoma.
Miscellaneous
II
Gibson, Mike
NCT04305795
VICCHN2055

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: